Shan Jialiang
MD @ Haibang Capital
Shan Jialiang is a angel investor at Haibang Capital focused on Health Care and Biotechnology. He is a managing partner of Haibang Medical Fund.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Shan Jialiang invests in
Stages Shan Jialiang invests in
Countries Shan Jialiang invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (100%)
- Biotechnology 2 (100%)
- Product Research 1 (50%)
Stage
- Angel 1 (50%)
- Series C 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Hopstem is a Hangzhou-based pharmaceutical company, engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering. | $29.6M / Series C / Aug 10, 2026 | ||
| T-Maximum develops CAR-T cell therapies for the treatment of brain tumors. T-Maximum's gene-editing allogeneic immune cell therapy adopts the version 3.0 program with completely independent intellectual property rights to realize allogeneic universal CAR-T therapy and solve the risk of graft-versus-host disease and rejection of allogeneicimmune cells. | Angel / Aug 20, 2021 |
Co-Investors
About Haibang Capital
Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.
Haibang Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Gang Liang
Founding Partner
|
|||
Li Xie
President
|
|||
Naxin Yao
Chairman & Executive Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Shan Jialiang invest in?
Shan Jialiang invests primarily in Health Care, Biotechnology and Product Research startups, most often at Angel and Series C stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Shan Jialiang?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Shan Jialiang last invest?
The most recent investment recorded for Shan Jialiang closed in Aug 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
